Cambrex Karlskoga AB, a subsidiary of Cambrex Corp., has entered into an agreement to acquire ProSyntest AS, a privately held API R&D company. ProSyntest employs 25 chemists at its Tallinn Technology Park location in Tallinn, Estonia. ProSyntest has expertise in chemical route selection and sample generation, rapid scaleup of products at kilo lab scale, as well as chiral and organometallic chemistries. The business will be renamed Cambrex Tallinn and Cambrex plans to add more process an...